Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=24783958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA19039(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дженетікс Інститут Інк., Дженетикс Институт Инк.filedCriticalДженетікс Інститут Інк.
Priority claimed from PCT/US1985/002405external-prioritypatent/WO1986003520A1/en
Publication of UA19039ApublicationCriticalpatent/UA19039A/uk
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Спосіб отримання людського еритропоетину передбачає культивування штамів еукаріотичних клітин, виділення і очищення цільового продукту шляхом концентрації, осадження, центрифугування і аффінної хроматографії. Попередньо конструюють рекомбінантні плазмідні ДНК, які забезпечують синтез еритропоетину, шляхом клонування кодуючого еритропоетин фрагмента ДНК.
Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them
Sequência de DNA vetor,plasmídeo,célula,proteína,mutante processo para o isolamento de ácidos nucléicos processo para a preparação de açúcares e empr egno